NCT04894370
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04894370
Title Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma (SPARTANA)
Acronym SPARTANA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Besancon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Hospitalier Universitaire de Besançon RECRUITING Besançon 25000 France Details
Centre Georges-François Leclerc (CGFL) RECRUITING Dijon France Details
Hôpital Franco-Britannique WITHDRAWN Levallois-Perret France Details
Centre Léon Bérard WITHDRAWN Lyon 69000 France Details
Hôpital Nord Franche Comté RECRUITING Montbéliard France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field